Explored as a possible aid for recovery and lean-mass preservation in frail or catabolic populations, though a Merck-sponsored Phase 2b trial in elderly hip-fracture patients (Adunsky et al., 2011, Archives of Gerontology and Geriatrics, PMID 21067829) was halted early over a cardiac safety signal rather than demonstrating a clear functional benefit
Tirzepatide for Medical Weight Loss in Roseville, CA Tirzepatide is an FDA-approved weight loss medication that can help patients achieve significant weight loss results and reduce the risks associated with obesity
Mechanistically, TGR5 regulates cardiomyocyte fatty acid uptake by modulating CD36 activity ( Bacteroides, Rikenella , and Prevotella genera ( CD36 overactivation disrupts cardiac lipid homeostasis by uncoupling fatty acid uptake from oxidation, resulting in lipid accumulation, lipotoxicity, and consequent cellular dysfunction
Optimal Timing
higher users report up to 1 mg in stacks